NCT00263484 Higher Frequency Zoledronic Acid in the Treatment of Multiple Myeloma Status COMPLETED Phase PHASE2
NCT00262925 Combination Chemotherapy and Alemtuzumab in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia Status TERMINATED Phase PHASE2
NCT00261612 Bortezomib, Rituximab and Dexamethasone (BORID) for Relapsed/Refractory Mantle Cell Lymphoma Status UNKNOWN Phase PHASE2
NCT00258245 Arsenic Trioxide and Ascorbic Acid Combined With Bortezomib, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma or Plasma Cell Leukemia Status COMPLETED Phase PHASE1
NCT00256776 MMVAR - Velcade: Study of Velcade for the Treatment of Myeloma Patients After Autologous Transplantation Status TERMINATED Phase PHASE3
NCT00253318 RAD001 Plus Docetaxel in Patients With Metastatic Breast Cancer Status TERMINATED Phase PHASE1
NCT00250926 Study of the Combination of Bortezomib, Dexamethasone, and Rituximab in Patients With Waldenstroms Macroglobulinemia Status COMPLETED Phase PHASE2
NCT00250718 Study: Treatment of Relapsed Lymphoid Malignancies With an Anti-Angiogenic Approach Status TERMINATED Phase PHASE2
NCT00248547 Aprepitant in Preventing Nausea and Vomiting in Patients Who Are Undergoing a Stem Cell Transplant Status COMPLETED Phase NA
NCT00247416 Effects of Carboplatin and Gemcitabine on Stage IIIB Pleural Effusion and Stage IV Lung Cancer Status COMPLETED Phase PHASE2
NCT00244855 Rituximab and Dexamethasone in Treating Patients With Low-Grade Non-Hodgkin Lymphoma Status COMPLETED Phase PHASE2
NCT00238225 Calcitriol, Ketoconazole, and Dexamethasone in Treating Patients With Metastatic or Unresectable Solid Tumors Status COMPLETED Phase PHASE1
NCT00235261 Effect of Paracetamol, Pregabalin and Dexamethasone on Pain and Opioid Requirements in Patients After Hip Operations Status COMPLETED Phase PHASE4
NCT00227682 Arsenic Trioxide, Thalidomide, Dexamethasone, and Ascorbic Acid in Treating Patients With Relapsed or Refractory Multiple Myeloma Status TERMINATED Phase PHASE2
NCT00227019 Phase 2 Trial of Bevacizumab in Combination With Pemetrexed Status COMPLETED Phase PHASE2
NCT00222105 A Study Evaluating Efficacy, Toxicity, Harvest Yield and Quality of Life Status COMPLETED Phase PHASE2
NCT00215943 Phase III Randomized Trial of Thalidomide/Dexamethasone Versus Vincristine+Adriamycin+Dexamethasone (VAD) Status TERMINATED Phase PHASE3
NCT00215748 Reduced Dexamethasone Pre-Medication Dose in Elderly Patients Receiving Weekly Docetaxel Status TERMINATED Phase PHASE2